256 related articles for article (PubMed ID: 22648057)
1. Genomics and epigenomics of the human glycome.
Zoldoš V; Novokmet M; Bečeheli I; Lauc G
Glycoconj J; 2013 Jan; 30(1):41-50. PubMed ID: 22648057
[TBL] [Abstract][Full Text] [Related]
2. Glycomics meets genomics, epigenomics and other high throughput omics for system biology studies.
Zoldoš V; Horvat T; Lauc G
Curr Opin Chem Biol; 2013 Feb; 17(1):34-40. PubMed ID: 23287290
[TBL] [Abstract][Full Text] [Related]
3. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.
Kori M; Aydin B; Gulfidan G; Beklen H; Kelesoglu N; Caliskan Iscan A; Turanli B; Erzik C; Karademir B; Arga KY
OMICS; 2021 Mar; 25(3):139-168. PubMed ID: 33404348
[TBL] [Abstract][Full Text] [Related]
4. Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.
Lauc G; Essafi A; Huffman JE; Hayward C; Knežević A; Kattla JJ; Polašek O; Gornik O; Vitart V; Abrahams JL; Pučić M; Novokmet M; Redžić I; Campbell S; Wild SH; Borovečki F; Wang W; Kolčić I; Zgaga L; Gyllensten U; Wilson JF; Wright AF; Hastie ND; Campbell H; Rudd PM; Rudan I
PLoS Genet; 2010 Dec; 6(12):e1001256. PubMed ID: 21203500
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of glycosylation is the quantum mechanics of biology.
Lauc G; Vojta A; Zoldoš V
Biochim Biophys Acta; 2014 Jan; 1840(1):65-70. PubMed ID: 23999089
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Genetics of Human Protein N-Glycosylation.
Krištić J; Sharapov SZ; Aulchenko YS
Adv Exp Med Biol; 2021; 1325():151-171. PubMed ID: 34495534
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: The human N-glycome.
Lauc G; Pezer M; Rudan I; Campbell H
Biochim Biophys Acta; 2016 Aug; 1860(8):1574-82. PubMed ID: 26500099
[TBL] [Abstract][Full Text] [Related]
8. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 2.
Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
Expert Rev Proteomics; 2018 Apr; 15(4):341-352. PubMed ID: 29521143
[TBL] [Abstract][Full Text] [Related]
9. Mapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode.
Agrawal P; Kurcon T; Pilobello KT; Rakus JF; Koppolu S; Liu Z; Batista BS; Eng WS; Hsu KL; Liang Y; Mahal LK
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4338-43. PubMed ID: 24591635
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome.
Zoldoš V; Horvat T; Novokmet M; Cuenin C; Mužinić A; Pučić M; Huffman JE; Gornik O; Polašek O; Campbell H; Hayward C; Wright AF; Rudan I; Owen K; McCarthy MI; Herceg Z; Lauc G
Epigenetics; 2012 Feb; 7(2):164-72. PubMed ID: 22395466
[TBL] [Abstract][Full Text] [Related]
11. Translation of genome to glycome: role of the Golgi apparatus.
Pothukuchi P; Agliarulo I; Russo D; Rizzo R; Russo F; Parashuraman S
FEBS Lett; 2019 Sep; 593(17):2390-2411. PubMed ID: 31330561
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the glycome after HDAC inhibition impact oncogenic potential in epigenetically plastic SW13 cells.
Montgomery MR; Hull EE
BMC Cancer; 2019 Jan; 19(1):79. PubMed ID: 30651077
[TBL] [Abstract][Full Text] [Related]
13. Extending Tlusty's rate distortion index theorem method to the glycome: do even 'low level' biochemical phenomena require sophisticated cognitive paradigms?
Wallace R
Biosystems; 2012 Mar; 107(3):145-52. PubMed ID: 22122974
[TBL] [Abstract][Full Text] [Related]
14. Plasma N-glycome composition associates with chronic low back pain.
Trbojević-Akmačić I; Vučković F; Vilaj M; Skelin A; Karssen LC; Krištić J; Jurić J; Momčilović A; Šimunović J; Mangino M; De Gregori M; Marchesini M; Dagostino C; Štambuk J; Novokmet M; Rauck R; Aulchenko YS; Primorac D; Kapural L; Buyse K; Mesotten D; Williams FMK; van Zundert J; Allegri M; Lauc G
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2124-2133. PubMed ID: 29981899
[TBL] [Abstract][Full Text] [Related]
15. Platform technology to identify potential disease markers and establish heritability and environmental determinants of the human serum N-glycome.
Tharmalingam T; Mariño K; Rudd PM
Carbohydr Res; 2010 Jul; 345(10):1280-2. PubMed ID: 20447618
[TBL] [Abstract][Full Text] [Related]
16. Glycomics, Glycoproteomics, and Glycogenomics: An Inter-Taxa Evolutionary Perspective.
West CM; Malzl D; Hykollari A; Wilson IBH
Mol Cell Proteomics; 2021; 20():100024. PubMed ID: 32994314
[TBL] [Abstract][Full Text] [Related]
17. Cell-Based Glycan Arrays-A Practical Guide to Dissect the Human Glycome.
Büll C; Joshi HJ; Clausen H; Narimatsu Y
STAR Protoc; 2020 Jun; 1(1):100017. PubMed ID: 33111073
[TBL] [Abstract][Full Text] [Related]
18. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
[TBL] [Abstract][Full Text] [Related]
19. Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease.
Gornik O; Pavić T; Lauc G
Biochim Biophys Acta; 2012 Sep; 1820(9):1318-26. PubMed ID: 22183029
[TBL] [Abstract][Full Text] [Related]
20. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
